Robin Parihar

2.8k total citations
47 papers, 2.3k citations indexed

About

Robin Parihar is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robin Parihar has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 33 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robin Parihar's work include Immune Cell Function and Interaction (32 papers), CAR-T cell therapy research (20 papers) and T-cell and B-cell Immunology (15 papers). Robin Parihar is often cited by papers focused on Immune Cell Function and Interaction (32 papers), CAR-T cell therapy research (20 papers) and T-cell and B-cell Immunology (15 papers). Robin Parihar collaborates with scholars based in United States, Czechia and Italy. Robin Parihar's co-authors include William E. Carson, Julie Dierksheide, Matthew Dysthe, Julie M. Roda, Susheela Tridandapani, Cynthia M. Magro, Stephen Gottschalk, Cliona M. Rooney, Bilal Omer and Leonid S. Metelitsa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Robin Parihar

45 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robin Parihar 1.5k 1.4k 482 342 197 47 2.3k
Sébastien Anguille 1.7k 1.1× 1.5k 1.1× 873 1.8× 151 0.4× 219 1.1× 88 2.7k
Sander Kelderman 1.2k 0.8× 1.4k 1.0× 526 1.1× 113 0.3× 295 1.5× 12 2.0k
Gundram Jung 1.7k 1.1× 1.4k 1.1× 871 1.8× 729 2.1× 120 0.6× 114 2.9k
Ralph Mocikat 1.5k 1.0× 825 0.6× 788 1.6× 463 1.4× 78 0.4× 65 2.3k
Wei‐Zen Wei 1.3k 0.9× 779 0.6× 664 1.4× 368 1.1× 76 0.4× 69 1.9k
Alfonso R. Sánchez-Paulete 1.5k 1.0× 1.3k 1.0× 402 0.8× 112 0.3× 162 0.8× 27 2.1k
Leopoldo Luistro 1.1k 0.8× 1.0k 0.7× 777 1.6× 281 0.8× 66 0.3× 28 2.2k
Arantza Azpilikueta 1.8k 1.2× 1.6k 1.2× 438 0.9× 118 0.3× 127 0.6× 47 2.4k
Inja Waldhauer 1.6k 1.0× 852 0.6× 741 1.5× 578 1.7× 111 0.6× 22 2.3k
Arnob Banerjee 2.0k 1.3× 1.2k 0.9× 959 2.0× 225 0.7× 97 0.5× 66 3.1k

Countries citing papers authored by Robin Parihar

Since Specialization
Citations

This map shows the geographic impact of Robin Parihar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Parihar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Parihar more than expected).

Fields of papers citing papers by Robin Parihar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Parihar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Parihar. The network helps show where Robin Parihar may publish in the future.

Co-authorship network of co-authors of Robin Parihar

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Parihar. A scholar is included among the top collaborators of Robin Parihar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Parihar. Robin Parihar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dysthe, Matthew, et al.. (2025). TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength. Cancer Immunology Research. 13(10). 1576–1590.
2.
Parihar, Robin, et al.. (2023). NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition. Current Hematologic Malignancy Reports. 18(6). 264–272. 3 indexed citations
3.
Nalawade, Saisha, Paul Shafer, Pradip Bajgain, et al.. (2021). Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. Journal for ImmunoTherapy of Cancer. 9(11). e003237–e003237. 56 indexed citations
4.
Shaw, Amanda Rosewell, Caroline E. Porter, Mary K. McKenna, et al.. (2021). Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Communications Biology. 4(1). 368–368. 34 indexed citations
5.
Parihar, Robin, Charlotte Helena Rivas, Bilal Omer, et al.. (2019). NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunology Research. 7(3). 363–375. 219 indexed citations
6.
Shum, Thomas, Bilal Omer, Haruko Tashiro, et al.. (2017). Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discovery. 7(11). 1238–1247. 220 indexed citations
7.
Campbell, Amanda R., Megan Duggan, Lorena P. Suarez‐Kelly, et al.. (2017). MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions. Cancer Immunology Research. 5(9). 778–789. 15 indexed citations
8.
9.
Jaime‐Ramirez, Alena Cristina, Bethany L. Mundy-Bosse, Natalie Jones, et al.. (2011). IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production. The Journal of Immunology. 186(6). 3401–3409. 81 indexed citations
10.
Roda, Julie M., Robin Parihar, Susheela Tridandapani, & William E. Carson. (2006). IL-21 enhances natural killer cell activation in response to antibody-coated tumor cells. Cancer Research. 66. 150–151. 1 indexed citations
11.
Roda, Julie M., Robin Parihar, Amy Lehman, et al.. (2006). Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets. The Journal of Immunology. 177(1). 120–129. 100 indexed citations
12.
Roda, Julie M., Robin Parihar, & William E. Carson. (2005). CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells. The Journal of Immunology. 175(3). 1619–1627. 96 indexed citations
13.
Parihar, Robin, P. Nadella, Julie Dierksheide, et al.. (2004). A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing Malignancies. Clinical Cancer Research. 10(15). 5027–5037. 92 indexed citations
14.
Lesinski, Gregory B., Mirela Anghelina, Jason M. Zimmerer, et al.. (2003). The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse. Journal of Clinical Investigation. 112(2). 170–180. 97 indexed citations
15.
Dakappagari, Naveen, John Pyles, Robin Parihar, et al.. (2003). A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses. The Journal of Immunology. 170(8). 4242–4253. 66 indexed citations
16.
Parihar, Robin, Julie Dierksheide, Yan Hu, & William E. Carson. (2002). IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. Journal of Clinical Investigation. 110(7). 983–992. 16 indexed citations
17.
Parihar, Robin, et al.. (2002). IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. Journal of Clinical Investigation. 110(7). 983–992. 137 indexed citations
18.
Fleming, Gini F., Neal J. Meropol, Gary L. Rosner, et al.. (2002). A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.. PubMed. 8(12). 3718–27. 39 indexed citations
19.
Parihar, Robin, et al.. (2002). IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. Journal of Clinical Investigation. 110(7). 983–992. 156 indexed citations
20.
Carson, William E., Robin Parihar, Matthew J. Lindemann, et al.. (2001). Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells. European Journal of Immunology. 31(10). 3016–3025. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Anguille Breakdown of academic impact, for papers by Sander Kelderman Breakdown of academic impact, for papers by Gundram Jung Breakdown of academic impact, for papers by Ralph Mocikat Breakdown of academic impact, for papers by Wei‐Zen Wei Breakdown of academic impact, for papers by Alfonso R. Sánchez-Paulete Breakdown of academic impact, for papers by Leopoldo Luistro Breakdown of academic impact, for papers by Arantza Azpilikueta Breakdown of academic impact, for papers by Inja Waldhauer Breakdown of academic impact, for papers by Arnob Banerjee
Rankless by CCL
2026